nodes	percent_of_prediction	percent_of_DWPC	metapath
Pimozide—CYP2E1—Fingolimod—multiple sclerosis	0.0931	0.166	CbGbCtD
Pimozide—CYP2D6—Fingolimod—multiple sclerosis	0.0444	0.079	CbGbCtD
Pimozide—CYP2E1—Mitoxantrone—multiple sclerosis	0.0438	0.0779	CbGbCtD
Pimozide—ABCB1—Methylprednisolone—multiple sclerosis	0.0303	0.054	CbGbCtD
Pimozide—CYP3A4—Fingolimod—multiple sclerosis	0.0282	0.0502	CbGbCtD
Pimozide—CYP3A7—Dexamethasone—multiple sclerosis	0.0235	0.0418	CbGbCtD
Pimozide—CYP3A7-CYP3A51P—Dexamethasone—multiple sclerosis	0.0235	0.0418	CbGbCtD
Pimozide—CYP2C19—Prednisone—multiple sclerosis	0.0228	0.0405	CbGbCtD
Pimozide—CYP2E1—Dexamethasone—multiple sclerosis	0.0227	0.0404	CbGbCtD
Pimozide—ABCB1—Mitoxantrone—multiple sclerosis	0.0221	0.0394	CbGbCtD
Pimozide—ABCB1—Betamethasone—multiple sclerosis	0.0197	0.0351	CbGbCtD
Pimozide—ABCB1—Prednisolone—multiple sclerosis	0.0195	0.0346	CbGbCtD
Pimozide—ABCB1—Prednisone—multiple sclerosis	0.0184	0.0327	CbGbCtD
Pimozide—CYP3A4—Methylprednisolone—multiple sclerosis	0.0182	0.0324	CbGbCtD
Pimozide—CYP3A5—Dexamethasone—multiple sclerosis	0.0176	0.0314	CbGbCtD
Pimozide—CYP2C19—Dexamethasone—multiple sclerosis	0.0142	0.0253	CbGbCtD
Pimozide—HTR2A—trigeminal nucleus—multiple sclerosis	0.0141	0.117	CbGeAlD
Pimozide—CYP3A4—Triamcinolone—multiple sclerosis	0.0138	0.0245	CbGbCtD
Pimozide—CYP3A4—Mitoxantrone—multiple sclerosis	0.0133	0.0236	CbGbCtD
Pimozide—CYP3A4—Betamethasone—multiple sclerosis	0.0118	0.021	CbGbCtD
Pimozide—CYP3A4—Prednisolone—multiple sclerosis	0.0117	0.0208	CbGbCtD
Pimozide—ABCB1—Dexamethasone—multiple sclerosis	0.0115	0.0204	CbGbCtD
Pimozide—CYP3A4—Prednisone—multiple sclerosis	0.011	0.0196	CbGbCtD
Pimozide—CYP2D6—Dexamethasone—multiple sclerosis	0.0108	0.0192	CbGbCtD
Pimozide—ABCB1—Methotrexate—multiple sclerosis	0.00922	0.0164	CbGbCtD
Pimozide—CYP3A4—Dexamethasone—multiple sclerosis	0.00688	0.0122	CbGbCtD
Pimozide—CALM1—trigeminal nerve—multiple sclerosis	0.00608	0.0503	CbGeAlD
Pimozide—CALM2—pons—multiple sclerosis	0.0043	0.0356	CbGeAlD
Pimozide—CALM1—pons—multiple sclerosis	0.00428	0.0354	CbGeAlD
Pimozide—HTR2A—trigeminal nerve—multiple sclerosis	0.0037	0.0307	CbGeAlD
Pimozide—OPRM1—nerve—multiple sclerosis	0.00307	0.0255	CbGeAlD
Pimozide—CALM2—pineal body—multiple sclerosis	0.00307	0.0254	CbGeAlD
Pimozide—CALM1—pineal body—multiple sclerosis	0.00305	0.0253	CbGeAlD
Pimozide—CALM2—peripheral nervous system—multiple sclerosis	0.00286	0.0237	CbGeAlD
Pimozide—CALM1—peripheral nervous system—multiple sclerosis	0.00285	0.0236	CbGeAlD
Pimozide—HTR2A—pons—multiple sclerosis	0.00261	0.0216	CbGeAlD
Pimozide—CALM2—nerve—multiple sclerosis	0.00223	0.0185	CbGeAlD
Pimozide—CALM1—nerve—multiple sclerosis	0.00222	0.0184	CbGeAlD
Pimozide—DRD2—nerve—multiple sclerosis	0.00205	0.017	CbGeAlD
Pimozide—HTR2A—pineal body—multiple sclerosis	0.00186	0.0154	CbGeAlD
Pimozide—HTR2A—peripheral nervous system—multiple sclerosis	0.00173	0.0144	CbGeAlD
Pimozide—CACNA1G—nervous system—multiple sclerosis	0.00153	0.0127	CbGeAlD
Pimozide—CACNA1G—central nervous system—multiple sclerosis	0.00147	0.0122	CbGeAlD
Pimozide—CACNA1G—cerebellum—multiple sclerosis	0.00144	0.0119	CbGeAlD
Pimozide—HTR2A—nerve—multiple sclerosis	0.00135	0.0112	CbGeAlD
Pimozide—OPRM1—brainstem—multiple sclerosis	0.00132	0.0109	CbGeAlD
Pimozide—CALM3—retina—multiple sclerosis	0.00118	0.00974	CbGeAlD
Pimozide—CACNA1G—brain—multiple sclerosis	0.00117	0.00968	CbGeAlD
Pimozide—DRD3—nervous system—multiple sclerosis	0.00109	0.00903	CbGeAlD
Pimozide—DRD3—central nervous system—multiple sclerosis	0.00105	0.00869	CbGeAlD
Pimozide—HTR6—nervous system—multiple sclerosis	0.00105	0.00869	CbGeAlD
Pimozide—HTR6—central nervous system—multiple sclerosis	0.00101	0.00837	CbGeAlD
Pimozide—HTR1A—brainstem—multiple sclerosis	0.000974	0.00807	CbGeAlD
Pimozide—OPRK1—nervous system—multiple sclerosis	0.000971	0.00805	CbGeAlD
Pimozide—CALM2—brainstem—multiple sclerosis	0.000957	0.00793	CbGeAlD
Pimozide—CALM1—brainstem—multiple sclerosis	0.000953	0.00789	CbGeAlD
Pimozide—OPRK1—central nervous system—multiple sclerosis	0.000935	0.00775	CbGeAlD
Pimozide—CALM2—retina—multiple sclerosis	0.000923	0.00765	CbGeAlD
Pimozide—CALM1—retina—multiple sclerosis	0.000919	0.00761	CbGeAlD
Pimozide—OPRK1—cerebellum—multiple sclerosis	0.000914	0.00757	CbGeAlD
Pimozide—DRD2—brainstem—multiple sclerosis	0.00088	0.00729	CbGeAlD
Pimozide—CALM3—medulla oblongata—multiple sclerosis	0.00085	0.00704	CbGeAlD
Pimozide—DRD2—retina—multiple sclerosis	0.000849	0.00703	CbGeAlD
Pimozide—OPRM1—midbrain—multiple sclerosis	0.00084	0.00696	CbGeAlD
Pimozide—DRD3—brain—multiple sclerosis	0.000833	0.0069	CbGeAlD
Pimozide—OPRM1—spinal cord—multiple sclerosis	0.00082	0.00679	CbGeAlD
Pimozide—HTR6—brain—multiple sclerosis	0.000802	0.00664	CbGeAlD
Pimozide—CALM3—midbrain—multiple sclerosis	0.000777	0.00644	CbGeAlD
Pimozide—CALM3—spinal cord—multiple sclerosis	0.000758	0.00628	CbGeAlD
Pimozide—OPRK1—brain—multiple sclerosis	0.000742	0.00615	CbGeAlD
Pimozide—OPRM1—nervous system—multiple sclerosis	0.000691	0.00572	CbGeAlD
Pimozide—CALM2—medulla oblongata—multiple sclerosis	0.000667	0.00553	CbGeAlD
Pimozide—OPRM1—central nervous system—multiple sclerosis	0.000665	0.00551	CbGeAlD
Pimozide—CALM1—medulla oblongata—multiple sclerosis	0.000664	0.0055	CbGeAlD
Pimozide—CHRM2—nervous system—multiple sclerosis	0.000629	0.00521	CbGeAlD
Pimozide—HTR1A—midbrain—multiple sclerosis	0.000621	0.00514	CbGeAlD
Pimozide—CALM2—midbrain—multiple sclerosis	0.00061	0.00505	CbGeAlD
Pimozide—CALM1—midbrain—multiple sclerosis	0.000607	0.00503	CbGeAlD
Pimozide—HTR1A—spinal cord—multiple sclerosis	0.000605	0.00502	CbGeAlD
Pimozide—CHRM2—central nervous system—multiple sclerosis	0.000605	0.00502	CbGeAlD
Pimozide—KCNH2—medulla oblongata—multiple sclerosis	0.000604	0.00501	CbGeAlD
Pimozide—CALM3—cerebellum—multiple sclerosis	0.000601	0.00498	CbGeAlD
Pimozide—CALM2—spinal cord—multiple sclerosis	0.000595	0.00493	CbGeAlD
Pimozide—CALM1—spinal cord—multiple sclerosis	0.000592	0.00491	CbGeAlD
Pimozide—HTR2A—brainstem—multiple sclerosis	0.00058	0.00481	CbGeAlD
Pimozide—DRD2—midbrain—multiple sclerosis	0.000561	0.00465	CbGeAlD
Pimozide—HTR2A—retina—multiple sclerosis	0.00056	0.00464	CbGeAlD
Pimozide—KCNH2—midbrain—multiple sclerosis	0.000552	0.00458	CbGeAlD
Pimozide—KCNH2—spinal cord—multiple sclerosis	0.000539	0.00447	CbGeAlD
Pimozide—CYP2D6—brainstem—multiple sclerosis	0.000529	0.00438	CbGeAlD
Pimozide—OPRM1—brain—multiple sclerosis	0.000528	0.00438	CbGeAlD
Pimozide—HTR1A—nervous system—multiple sclerosis	0.00051	0.00423	CbGeAlD
Pimozide—CALM2—nervous system—multiple sclerosis	0.000501	0.00415	CbGeAlD
Pimozide—CALM1—nervous system—multiple sclerosis	0.000499	0.00414	CbGeAlD
Pimozide—HTR1A—central nervous system—multiple sclerosis	0.000491	0.00407	CbGeAlD
Pimozide—CALM3—brain—multiple sclerosis	0.000488	0.00404	CbGeAlD
Pimozide—CALM2—central nervous system—multiple sclerosis	0.000483	0.004	CbGeAlD
Pimozide—CHRM2—brain—multiple sclerosis	0.000481	0.00398	CbGeAlD
Pimozide—CALM1—central nervous system—multiple sclerosis	0.000481	0.00398	CbGeAlD
Pimozide—HTR1A—cerebellum—multiple sclerosis	0.00048	0.00398	CbGeAlD
Pimozide—CALM2—cerebellum—multiple sclerosis	0.000472	0.00391	CbGeAlD
Pimozide—CALM1—cerebellum—multiple sclerosis	0.00047	0.00389	CbGeAlD
Pimozide—CYP2E1—medulla oblongata—multiple sclerosis	0.000466	0.00386	CbGeAlD
Pimozide—DRD2—nervous system—multiple sclerosis	0.000461	0.00382	CbGeAlD
Pimozide—KCNH2—nervous system—multiple sclerosis	0.000454	0.00376	CbGeAlD
Pimozide—DRD2—central nervous system—multiple sclerosis	0.000444	0.00368	CbGeAlD
Pimozide—KCNH2—central nervous system—multiple sclerosis	0.000437	0.00362	CbGeAlD
Pimozide—DRD2—cerebellum—multiple sclerosis	0.000434	0.00359	CbGeAlD
Pimozide—KCNH2—cerebellum—multiple sclerosis	0.000427	0.00354	CbGeAlD
Pimozide—CYP2E1—spinal cord—multiple sclerosis	0.000415	0.00344	CbGeAlD
Pimozide—HTR2A—medulla oblongata—multiple sclerosis	0.000405	0.00335	CbGeAlD
Pimozide—Gynaecomastia—Methotrexate—multiple sclerosis	0.000402	0.00286	CcSEcCtD
Pimozide—HTR1A—brain—multiple sclerosis	0.00039	0.00323	CbGeAlD
Pimozide—Urticaria—Cladribine—multiple sclerosis	0.000389	0.00277	CcSEcCtD
Pimozide—Weight increased—Triamcinolone—multiple sclerosis	0.000388	0.00276	CcSEcCtD
Pimozide—Weight increased—Methylprednisolone—multiple sclerosis	0.000388	0.00276	CcSEcCtD
Pimozide—Skin disorder—Azathioprine—multiple sclerosis	0.000387	0.00275	CcSEcCtD
Pimozide—CALM2—brain—multiple sclerosis	0.000383	0.00318	CbGeAlD
Pimozide—CALM1—brain—multiple sclerosis	0.000381	0.00316	CbGeAlD
Pimozide—Hypotension—Azathioprine—multiple sclerosis	0.000372	0.00265	CcSEcCtD
Pimozide—Vision blurred—Mitoxantrone—multiple sclerosis	0.000372	0.00264	CcSEcCtD
Pimozide—HTR2A—midbrain—multiple sclerosis	0.00037	0.00306	CbGeAlD
Pimozide—ABCB1—retina—multiple sclerosis	0.000367	0.00304	CbGeAlD
Pimozide—Anaemia—Mitoxantrone—multiple sclerosis	0.000364	0.00259	CcSEcCtD
Pimozide—Sweating—Methylprednisolone—multiple sclerosis	0.000364	0.00259	CcSEcCtD
Pimozide—HRH1—nervous system—multiple sclerosis	0.000364	0.00302	CbGeAlD
Pimozide—Musculoskeletal discomfort—Azathioprine—multiple sclerosis	0.000363	0.00258	CcSEcCtD
Pimozide—HTR2A—spinal cord—multiple sclerosis	0.000361	0.00299	CbGeAlD
Pimozide—Visual impairment—Prednisolone—multiple sclerosis	0.000358	0.00255	CcSEcCtD
Pimozide—Leukopenia—Mitoxantrone—multiple sclerosis	0.000353	0.00251	CcSEcCtD
Pimozide—Weight increased—Dexamethasone—multiple sclerosis	0.000352	0.00251	CcSEcCtD
Pimozide—Weight increased—Betamethasone—multiple sclerosis	0.000352	0.00251	CcSEcCtD
Pimozide—DRD2—brain—multiple sclerosis	0.000352	0.00292	CbGeAlD
Pimozide—Asthenia—Cladribine—multiple sclerosis	0.000351	0.0025	CcSEcCtD
Pimozide—HRH1—central nervous system—multiple sclerosis	0.00035	0.0029	CbGeAlD
Pimozide—Weight decreased—Dexamethasone—multiple sclerosis	0.00035	0.00249	CcSEcCtD
Pimozide—Weight decreased—Betamethasone—multiple sclerosis	0.00035	0.00249	CcSEcCtD
Pimozide—CYP2E1—nervous system—multiple sclerosis	0.00035	0.0029	CbGeAlD
Pimozide—KCNH2—brain—multiple sclerosis	0.000347	0.00288	CbGeAlD
Pimozide—Pruritus—Cladribine—multiple sclerosis	0.000346	0.00246	CcSEcCtD
Pimozide—Visual disturbance—Methotrexate—multiple sclerosis	0.000344	0.00245	CcSEcCtD
Pimozide—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000344	0.00244	CcSEcCtD
Pimozide—Convulsion—Mitoxantrone—multiple sclerosis	0.000342	0.00243	CcSEcCtD
Pimozide—Hypertension—Mitoxantrone—multiple sclerosis	0.00034	0.00242	CcSEcCtD
Pimozide—CYP2E1—central nervous system—multiple sclerosis	0.000337	0.00279	CbGeAlD
Pimozide—Myalgia—Mitoxantrone—multiple sclerosis	0.000336	0.00239	CcSEcCtD
Pimozide—Chest pain—Mitoxantrone—multiple sclerosis	0.000336	0.00239	CcSEcCtD
Pimozide—Connective tissue disorder—Methylprednisolone—multiple sclerosis	0.000335	0.00238	CcSEcCtD
Pimozide—Diarrhoea—Cladribine—multiple sclerosis	0.000335	0.00238	CcSEcCtD
Pimozide—CYP2E1—cerebellum—multiple sclerosis	0.000329	0.00273	CbGeAlD
Pimozide—Visual impairment—Methylprednisolone—multiple sclerosis	0.000329	0.00234	CcSEcCtD
Pimozide—Dizziness—Cladribine—multiple sclerosis	0.000324	0.0023	CcSEcCtD
Pimozide—Eye disorder—Methylprednisolone—multiple sclerosis	0.000319	0.00227	CcSEcCtD
Pimozide—Shock—Mitoxantrone—multiple sclerosis	0.000317	0.00225	CcSEcCtD
Pimozide—Cardiac disorder—Methylprednisolone—multiple sclerosis	0.000316	0.00225	CcSEcCtD
Pimozide—Tachycardia—Mitoxantrone—multiple sclerosis	0.000314	0.00223	CcSEcCtD
Pimozide—Skin disorder—Mitoxantrone—multiple sclerosis	0.000312	0.00222	CcSEcCtD
Pimozide—Vomiting—Cladribine—multiple sclerosis	0.000311	0.00221	CcSEcCtD
Pimozide—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.000311	0.00221	CcSEcCtD
Pimozide—Erectile dysfunction—Prednisone—multiple sclerosis	0.000311	0.00221	CcSEcCtD
Pimozide—Rash—Cladribine—multiple sclerosis	0.000309	0.0022	CcSEcCtD
Pimozide—Dermatitis—Cladribine—multiple sclerosis	0.000308	0.00219	CcSEcCtD
Pimozide—Weight increased—Prednisone—multiple sclerosis	0.000307	0.00218	CcSEcCtD
Pimozide—Anorexia—Mitoxantrone—multiple sclerosis	0.000307	0.00218	CcSEcCtD
Pimozide—Headache—Cladribine—multiple sclerosis	0.000307	0.00218	CcSEcCtD
Pimozide—Weight decreased—Prednisone—multiple sclerosis	0.000305	0.00217	CcSEcCtD
Pimozide—Vision blurred—Prednisolone—multiple sclerosis	0.000305	0.00217	CcSEcCtD
Pimozide—HTR2A—nervous system—multiple sclerosis	0.000304	0.00252	CbGeAlD
Pimozide—Hypotension—Mitoxantrone—multiple sclerosis	0.000301	0.00214	CcSEcCtD
Pimozide—Depression—Prednisone—multiple sclerosis	0.0003	0.00213	CcSEcCtD
Pimozide—Visual impairment—Dexamethasone—multiple sclerosis	0.000299	0.00213	CcSEcCtD
Pimozide—Visual impairment—Betamethasone—multiple sclerosis	0.000299	0.00213	CcSEcCtD
Pimozide—Mental disorder—Methylprednisolone—multiple sclerosis	0.000299	0.00212	CcSEcCtD
Pimozide—Breast disorder—Methotrexate—multiple sclerosis	0.000295	0.0021	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000293	0.00209	CcSEcCtD
Pimozide—HTR2A—central nervous system—multiple sclerosis	0.000293	0.00243	CbGeAlD
Pimozide—Nausea—Cladribine—multiple sclerosis	0.000291	0.00207	CcSEcCtD
Pimozide—Syncope—Prednisolone—multiple sclerosis	0.00029	0.00206	CcSEcCtD
Pimozide—Eye disorder—Betamethasone—multiple sclerosis	0.00029	0.00206	CcSEcCtD
Pimozide—Eye disorder—Dexamethasone—multiple sclerosis	0.00029	0.00206	CcSEcCtD
Pimozide—HTR2A—cerebellum—multiple sclerosis	0.000286	0.00237	CbGeAlD
Pimozide—Somnolence—Mitoxantrone—multiple sclerosis	0.000286	0.00203	CcSEcCtD
Pimozide—Loss of consciousness—Prednisolone—multiple sclerosis	0.000284	0.00202	CcSEcCtD
Pimozide—CYP3A4—nervous system—multiple sclerosis	0.000281	0.00233	CbGeAlD
Pimozide—Convulsion—Prednisolone—multiple sclerosis	0.00028	0.00199	CcSEcCtD
Pimozide—Decreased appetite—Mitoxantrone—multiple sclerosis	0.00028	0.00199	CcSEcCtD
Pimozide—Hypertension—Prednisolone—multiple sclerosis	0.000279	0.00199	CcSEcCtD
Pimozide—Eosinophilia—Methotrexate—multiple sclerosis	0.000279	0.00199	CcSEcCtD
Pimozide—HRH1—brain—multiple sclerosis	0.000278	0.00231	CbGeAlD
Pimozide—CYP2D6—nervous system—multiple sclerosis	0.000277	0.00229	CbGeAlD
Pimozide—Constipation—Mitoxantrone—multiple sclerosis	0.000275	0.00196	CcSEcCtD
Pimozide—Diarrhoea—Azathioprine—multiple sclerosis	0.000272	0.00194	CcSEcCtD
Pimozide—CYP3A4—central nervous system—multiple sclerosis	0.000271	0.00225	CbGeAlD
Pimozide—Abdominal discomfort—Methotrexate—multiple sclerosis	0.00027	0.00192	CcSEcCtD
Pimozide—Pancytopenia—Methotrexate—multiple sclerosis	0.000268	0.0019	CcSEcCtD
Pimozide—CYP2E1—brain—multiple sclerosis	0.000267	0.00222	CbGeAlD
Pimozide—Syncope—Triamcinolone—multiple sclerosis	0.000267	0.0019	CcSEcCtD
Pimozide—CYP2D6—central nervous system—multiple sclerosis	0.000267	0.00221	CbGeAlD
Pimozide—Syncope—Methylprednisolone—multiple sclerosis	0.000266	0.00189	CcSEcCtD
Pimozide—Connective tissue disorder—Prednisone—multiple sclerosis	0.000265	0.00189	CcSEcCtD
Pimozide—ABCB1—medulla oblongata—multiple sclerosis	0.000265	0.0022	CbGeAlD
Pimozide—Dizziness—Azathioprine—multiple sclerosis	0.000263	0.00187	CcSEcCtD
Pimozide—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000261	0.00186	CcSEcCtD
Pimozide—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000261	0.00186	CcSEcCtD
Pimozide—CYP2D6—cerebellum—multiple sclerosis	0.000261	0.00216	CbGeAlD
Pimozide—Shock—Prednisolone—multiple sclerosis	0.00026	0.00185	CcSEcCtD
Pimozide—Erectile dysfunction—Methotrexate—multiple sclerosis	0.00026	0.00185	CcSEcCtD
Pimozide—Convulsion—Triamcinolone—multiple sclerosis	0.000258	0.00183	CcSEcCtD
Pimozide—Tachycardia—Prednisolone—multiple sclerosis	0.000258	0.00183	CcSEcCtD
Pimozide—Convulsion—Methylprednisolone—multiple sclerosis	0.000257	0.00183	CcSEcCtD
Pimozide—Hypertension—Triamcinolone—multiple sclerosis	0.000257	0.00183	CcSEcCtD
Pimozide—Hypertension—Methylprednisolone—multiple sclerosis	0.000256	0.00182	CcSEcCtD
Pimozide—Urticaria—Mitoxantrone—multiple sclerosis	0.000256	0.00182	CcSEcCtD
Pimozide—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000255	0.00182	CcSEcCtD
Pimozide—Myalgia—Triamcinolone—multiple sclerosis	0.000253	0.0018	CcSEcCtD
Pimozide—Vomiting—Azathioprine—multiple sclerosis	0.000253	0.0018	CcSEcCtD
Pimozide—Myalgia—Methylprednisolone—multiple sclerosis	0.000253	0.0018	CcSEcCtD
Pimozide—Eye disorder—Prednisone—multiple sclerosis	0.000252	0.00179	CcSEcCtD
Pimozide—Drowsiness—Methotrexate—multiple sclerosis	0.000251	0.00179	CcSEcCtD
Pimozide—Rash—Azathioprine—multiple sclerosis	0.000251	0.00179	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000251	0.00178	CcSEcCtD
Pimozide—Dermatitis—Azathioprine—multiple sclerosis	0.000251	0.00178	CcSEcCtD
Pimozide—Depression—Methotrexate—multiple sclerosis	0.000251	0.00178	CcSEcCtD
Pimozide—Headache—Azathioprine—multiple sclerosis	0.000249	0.00177	CcSEcCtD
Pimozide—Dry mouth—Triamcinolone—multiple sclerosis	0.000248	0.00176	CcSEcCtD
Pimozide—ABCB1—midbrain—multiple sclerosis	0.000242	0.00201	CbGeAlD
Pimozide—Syncope—Betamethasone—multiple sclerosis	0.000242	0.00172	CcSEcCtD
Pimozide—Syncope—Dexamethasone—multiple sclerosis	0.000242	0.00172	CcSEcCtD
Pimozide—Sweating—Methotrexate—multiple sclerosis	0.000241	0.00171	CcSEcCtD
Pimozide—Shock—Triamcinolone—multiple sclerosis	0.000239	0.0017	CcSEcCtD
Pimozide—Insomnia—Prednisolone—multiple sclerosis	0.000239	0.0017	CcSEcCtD
Pimozide—Shock—Methylprednisolone—multiple sclerosis	0.000238	0.0017	CcSEcCtD
Pimozide—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000238	0.00169	CcSEcCtD
Pimozide—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000237	0.00169	CcSEcCtD
Pimozide—Loss of consciousness—Betamethasone—multiple sclerosis	0.000237	0.00169	CcSEcCtD
Pimozide—Tachycardia—Triamcinolone—multiple sclerosis	0.000237	0.00169	CcSEcCtD
Pimozide—Mental disorder—Prednisone—multiple sclerosis	0.000237	0.00168	CcSEcCtD
Pimozide—ABCB1—spinal cord—multiple sclerosis	0.000236	0.00196	CbGeAlD
Pimozide—Nausea—Azathioprine—multiple sclerosis	0.000236	0.00168	CcSEcCtD
Pimozide—Tachycardia—Methylprednisolone—multiple sclerosis	0.000236	0.00168	CcSEcCtD
Pimozide—Skin disorder—Methylprednisolone—multiple sclerosis	0.000235	0.00167	CcSEcCtD
Pimozide—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000235	0.00167	CcSEcCtD
Pimozide—Agranulocytosis—Methotrexate—multiple sclerosis	0.000235	0.00167	CcSEcCtD
Pimozide—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000234	0.00167	CcSEcCtD
Pimozide—Convulsion—Dexamethasone—multiple sclerosis	0.000234	0.00166	CcSEcCtD
Pimozide—Convulsion—Betamethasone—multiple sclerosis	0.000234	0.00166	CcSEcCtD
Pimozide—Hypertension—Betamethasone—multiple sclerosis	0.000233	0.00166	CcSEcCtD
Pimozide—Hypertension—Dexamethasone—multiple sclerosis	0.000233	0.00166	CcSEcCtD
Pimozide—HTR2A—brain—multiple sclerosis	0.000232	0.00193	CbGeAlD
Pimozide—Asthenia—Mitoxantrone—multiple sclerosis	0.000231	0.00164	CcSEcCtD
Pimozide—Myalgia—Betamethasone—multiple sclerosis	0.00023	0.00163	CcSEcCtD
Pimozide—Myalgia—Dexamethasone—multiple sclerosis	0.00023	0.00163	CcSEcCtD
Pimozide—Hypotension—Methylprednisolone—multiple sclerosis	0.000226	0.00161	CcSEcCtD
Pimozide—Vision blurred—Prednisone—multiple sclerosis	0.000221	0.00158	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000221	0.00157	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000221	0.00157	CcSEcCtD
Pimozide—Diarrhoea—Mitoxantrone—multiple sclerosis	0.00022	0.00157	CcSEcCtD
Pimozide—Insomnia—Triamcinolone—multiple sclerosis	0.00022	0.00156	CcSEcCtD
Pimozide—Insomnia—Methylprednisolone—multiple sclerosis	0.000219	0.00156	CcSEcCtD
Pimozide—Visual impairment—Methotrexate—multiple sclerosis	0.000217	0.00155	CcSEcCtD
Pimozide—Anaemia—Prednisone—multiple sclerosis	0.000217	0.00155	CcSEcCtD
Pimozide—Shock—Betamethasone—multiple sclerosis	0.000217	0.00154	CcSEcCtD
Pimozide—Shock—Dexamethasone—multiple sclerosis	0.000217	0.00154	CcSEcCtD
Pimozide—Nervous system disorder—Betamethasone—multiple sclerosis	0.000216	0.00154	CcSEcCtD
Pimozide—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000216	0.00154	CcSEcCtD
Pimozide—Agitation—Prednisone—multiple sclerosis	0.000216	0.00154	CcSEcCtD
Pimozide—Tachycardia—Dexamethasone—multiple sclerosis	0.000215	0.00153	CcSEcCtD
Pimozide—Tachycardia—Betamethasone—multiple sclerosis	0.000215	0.00153	CcSEcCtD
Pimozide—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000213	0.00151	CcSEcCtD
Pimozide—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000213	0.00151	CcSEcCtD
Pimozide—CYP2D6—brain—multiple sclerosis	0.000212	0.00175	CbGeAlD
Pimozide—Eye disorder—Methotrexate—multiple sclerosis	0.000211	0.0015	CcSEcCtD
Pimozide—Syncope—Prednisone—multiple sclerosis	0.000211	0.0015	CcSEcCtD
Pimozide—Anorexia—Dexamethasone—multiple sclerosis	0.00021	0.00149	CcSEcCtD
Pimozide—Anorexia—Betamethasone—multiple sclerosis	0.00021	0.00149	CcSEcCtD
Pimozide—Urticaria—Prednisolone—multiple sclerosis	0.00021	0.00149	CcSEcCtD
Pimozide—Cardiac disorder—Methotrexate—multiple sclerosis	0.000209	0.00149	CcSEcCtD
Pimozide—Loss of consciousness—Prednisone—multiple sclerosis	0.000207	0.00147	CcSEcCtD
Pimozide—Hypotension—Dexamethasone—multiple sclerosis	0.000206	0.00146	CcSEcCtD
Pimozide—Hypotension—Betamethasone—multiple sclerosis	0.000206	0.00146	CcSEcCtD
Pimozide—Vomiting—Mitoxantrone—multiple sclerosis	0.000205	0.00146	CcSEcCtD
Pimozide—Convulsion—Prednisone—multiple sclerosis	0.000204	0.00145	CcSEcCtD
Pimozide—Hypertension—Prednisone—multiple sclerosis	0.000203	0.00144	CcSEcCtD
Pimozide—Rash—Mitoxantrone—multiple sclerosis	0.000203	0.00144	CcSEcCtD
Pimozide—Dermatitis—Mitoxantrone—multiple sclerosis	0.000203	0.00144	CcSEcCtD
Pimozide—Headache—Mitoxantrone—multiple sclerosis	0.000202	0.00143	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000201	0.00143	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000201	0.00143	CcSEcCtD
Pimozide—Myalgia—Prednisone—multiple sclerosis	0.0002	0.00142	CcSEcCtD
Pimozide—ABCB1—nervous system—multiple sclerosis	0.000199	0.00165	CbGeAlD
Pimozide—Insomnia—Betamethasone—multiple sclerosis	0.000199	0.00142	CcSEcCtD
Pimozide—Insomnia—Dexamethasone—multiple sclerosis	0.000199	0.00142	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000199	0.00141	CcSEcCtD
Pimozide—Mental disorder—Methotrexate—multiple sclerosis	0.000198	0.00141	CcSEcCtD
Pimozide—Urticaria—Triamcinolone—multiple sclerosis	0.000193	0.00137	CcSEcCtD
Pimozide—Urticaria—Methylprednisolone—multiple sclerosis	0.000192	0.00137	CcSEcCtD
Pimozide—ABCB1—central nervous system—multiple sclerosis	0.000192	0.00159	CbGeAlD
Pimozide—Decreased appetite—Dexamethasone—multiple sclerosis	0.000191	0.00136	CcSEcCtD
Pimozide—Decreased appetite—Betamethasone—multiple sclerosis	0.000191	0.00136	CcSEcCtD
Pimozide—Nausea—Mitoxantrone—multiple sclerosis	0.000191	0.00136	CcSEcCtD
Pimozide—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.00019	0.00135	CcSEcCtD
Pimozide—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.00019	0.00135	CcSEcCtD
Pimozide—Shock—Prednisone—multiple sclerosis	0.000189	0.00134	CcSEcCtD
Pimozide—Nervous system disorder—Prednisone—multiple sclerosis	0.000188	0.00134	CcSEcCtD
Pimozide—ABCB1—cerebellum—multiple sclerosis	0.000187	0.00155	CbGeAlD
Pimozide—Tachycardia—Prednisone—multiple sclerosis	0.000187	0.00133	CcSEcCtD
Pimozide—Skin disorder—Prednisone—multiple sclerosis	0.000186	0.00133	CcSEcCtD
Pimozide—Hyperhidrosis—Prednisone—multiple sclerosis	0.000185	0.00132	CcSEcCtD
Pimozide—Vision blurred—Methotrexate—multiple sclerosis	0.000185	0.00132	CcSEcCtD
Pimozide—Anorexia—Prednisone—multiple sclerosis	0.000183	0.0013	CcSEcCtD
Pimozide—Anaemia—Methotrexate—multiple sclerosis	0.000182	0.00129	CcSEcCtD
Pimozide—Leukopenia—Methotrexate—multiple sclerosis	0.000176	0.00125	CcSEcCtD
Pimozide—Urticaria—Dexamethasone—multiple sclerosis	0.000175	0.00124	CcSEcCtD
Pimozide—Urticaria—Betamethasone—multiple sclerosis	0.000175	0.00124	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000175	0.00124	CcSEcCtD
Pimozide—Dizziness—Prednisolone—multiple sclerosis	0.000175	0.00124	CcSEcCtD
Pimozide—Asthenia—Triamcinolone—multiple sclerosis	0.000174	0.00124	CcSEcCtD
Pimozide—Asthenia—Methylprednisolone—multiple sclerosis	0.000174	0.00124	CcSEcCtD
Pimozide—Insomnia—Prednisone—multiple sclerosis	0.000173	0.00123	CcSEcCtD
Pimozide—Pruritus—Triamcinolone—multiple sclerosis	0.000172	0.00122	CcSEcCtD
Pimozide—Pruritus—Methylprednisolone—multiple sclerosis	0.000171	0.00122	CcSEcCtD
Pimozide—Convulsion—Methotrexate—multiple sclerosis	0.00017	0.00121	CcSEcCtD
Pimozide—Chest pain—Methotrexate—multiple sclerosis	0.000167	0.00119	CcSEcCtD
Pimozide—Myalgia—Methotrexate—multiple sclerosis	0.000167	0.00119	CcSEcCtD
Pimozide—Decreased appetite—Prednisone—multiple sclerosis	0.000167	0.00119	CcSEcCtD
Pimozide—Rash—Prednisolone—multiple sclerosis	0.000166	0.00118	CcSEcCtD
Pimozide—Dermatitis—Prednisolone—multiple sclerosis	0.000166	0.00118	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000166	0.00118	CcSEcCtD
Pimozide—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000166	0.00118	CcSEcCtD
Pimozide—Headache—Prednisolone—multiple sclerosis	0.000165	0.00118	CcSEcCtD
Pimozide—Constipation—Prednisone—multiple sclerosis	0.000164	0.00117	CcSEcCtD
Pimozide—Dizziness—Triamcinolone—multiple sclerosis	0.000161	0.00114	CcSEcCtD
Pimozide—Dizziness—Methylprednisolone—multiple sclerosis	0.00016	0.00114	CcSEcCtD
Pimozide—Asthenia—Dexamethasone—multiple sclerosis	0.000158	0.00112	CcSEcCtD
Pimozide—Asthenia—Betamethasone—multiple sclerosis	0.000158	0.00112	CcSEcCtD
Pimozide—Nervous system disorder—Methotrexate—multiple sclerosis	0.000157	0.00112	CcSEcCtD
Pimozide—Nausea—Prednisolone—multiple sclerosis	0.000157	0.00112	CcSEcCtD
Pimozide—Pruritus—Dexamethasone—multiple sclerosis	0.000156	0.00111	CcSEcCtD
Pimozide—Pruritus—Betamethasone—multiple sclerosis	0.000156	0.00111	CcSEcCtD
Pimozide—Skin disorder—Methotrexate—multiple sclerosis	0.000156	0.00111	CcSEcCtD
Pimozide—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000155	0.0011	CcSEcCtD
Pimozide—Vomiting—Triamcinolone—multiple sclerosis	0.000154	0.0011	CcSEcCtD
Pimozide—Vomiting—Methylprednisolone—multiple sclerosis	0.000154	0.0011	CcSEcCtD
Pimozide—Rash—Triamcinolone—multiple sclerosis	0.000153	0.00109	CcSEcCtD
Pimozide—Dermatitis—Triamcinolone—multiple sclerosis	0.000153	0.00109	CcSEcCtD
Pimozide—Anorexia—Methotrexate—multiple sclerosis	0.000153	0.00109	CcSEcCtD
Pimozide—Rash—Methylprednisolone—multiple sclerosis	0.000153	0.00109	CcSEcCtD
Pimozide—Dermatitis—Methylprednisolone—multiple sclerosis	0.000153	0.00109	CcSEcCtD
Pimozide—Urticaria—Prednisone—multiple sclerosis	0.000152	0.00108	CcSEcCtD
Pimozide—ABCB1—brain—multiple sclerosis	0.000152	0.00126	CbGeAlD
Pimozide—Headache—Triamcinolone—multiple sclerosis	0.000152	0.00108	CcSEcCtD
Pimozide—Headache—Methylprednisolone—multiple sclerosis	0.000152	0.00108	CcSEcCtD
Pimozide—Diarrhoea—Dexamethasone—multiple sclerosis	0.000151	0.00107	CcSEcCtD
Pimozide—Diarrhoea—Betamethasone—multiple sclerosis	0.000151	0.00107	CcSEcCtD
Pimozide—Hypotension—Methotrexate—multiple sclerosis	0.00015	0.00107	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000146	0.00104	CcSEcCtD
Pimozide—Dizziness—Dexamethasone—multiple sclerosis	0.000146	0.00104	CcSEcCtD
Pimozide—Dizziness—Betamethasone—multiple sclerosis	0.000146	0.00104	CcSEcCtD
Pimozide—Insomnia—Methotrexate—multiple sclerosis	0.000145	0.00103	CcSEcCtD
Pimozide—Nausea—Triamcinolone—multiple sclerosis	0.000144	0.00103	CcSEcCtD
Pimozide—Nausea—Methylprednisolone—multiple sclerosis	0.000144	0.00102	CcSEcCtD
Pimozide—Somnolence—Methotrexate—multiple sclerosis	0.000142	0.00101	CcSEcCtD
Pimozide—Vomiting—Betamethasone—multiple sclerosis	0.00014	0.000996	CcSEcCtD
Pimozide—Vomiting—Dexamethasone—multiple sclerosis	0.00014	0.000996	CcSEcCtD
Pimozide—Decreased appetite—Methotrexate—multiple sclerosis	0.000139	0.000991	CcSEcCtD
Pimozide—Rash—Betamethasone—multiple sclerosis	0.000139	0.000988	CcSEcCtD
Pimozide—Rash—Dexamethasone—multiple sclerosis	0.000139	0.000988	CcSEcCtD
Pimozide—Dermatitis—Dexamethasone—multiple sclerosis	0.000139	0.000987	CcSEcCtD
Pimozide—Dermatitis—Betamethasone—multiple sclerosis	0.000139	0.000987	CcSEcCtD
Pimozide—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000138	0.000985	CcSEcCtD
Pimozide—Headache—Dexamethasone—multiple sclerosis	0.000138	0.000982	CcSEcCtD
Pimozide—Headache—Betamethasone—multiple sclerosis	0.000138	0.000982	CcSEcCtD
Pimozide—Asthenia—Prednisone—multiple sclerosis	0.000138	0.000979	CcSEcCtD
Pimozide—Pruritus—Prednisone—multiple sclerosis	0.000136	0.000965	CcSEcCtD
Pimozide—Diarrhoea—Prednisone—multiple sclerosis	0.000131	0.000934	CcSEcCtD
Pimozide—Nausea—Betamethasone—multiple sclerosis	0.000131	0.000931	CcSEcCtD
Pimozide—Nausea—Dexamethasone—multiple sclerosis	0.000131	0.000931	CcSEcCtD
Pimozide—Urticaria—Methotrexate—multiple sclerosis	0.000127	0.000906	CcSEcCtD
Pimozide—Dizziness—Prednisone—multiple sclerosis	0.000127	0.000902	CcSEcCtD
Pimozide—Vomiting—Prednisone—multiple sclerosis	0.000122	0.000868	CcSEcCtD
Pimozide—Rash—Prednisone—multiple sclerosis	0.000121	0.00086	CcSEcCtD
Pimozide—Dermatitis—Prednisone—multiple sclerosis	0.000121	0.00086	CcSEcCtD
Pimozide—Headache—Prednisone—multiple sclerosis	0.00012	0.000855	CcSEcCtD
Pimozide—Asthenia—Methotrexate—multiple sclerosis	0.000115	0.000818	CcSEcCtD
Pimozide—Nausea—Prednisone—multiple sclerosis	0.000114	0.000811	CcSEcCtD
Pimozide—Pruritus—Methotrexate—multiple sclerosis	0.000113	0.000807	CcSEcCtD
Pimozide—Diarrhoea—Methotrexate—multiple sclerosis	0.00011	0.00078	CcSEcCtD
Pimozide—Dizziness—Methotrexate—multiple sclerosis	0.000106	0.000754	CcSEcCtD
Pimozide—Vomiting—Methotrexate—multiple sclerosis	0.000102	0.000725	CcSEcCtD
Pimozide—Rash—Methotrexate—multiple sclerosis	0.000101	0.000719	CcSEcCtD
Pimozide—Dermatitis—Methotrexate—multiple sclerosis	0.000101	0.000718	CcSEcCtD
Pimozide—Headache—Methotrexate—multiple sclerosis	0.0001	0.000714	CcSEcCtD
Pimozide—Nausea—Methotrexate—multiple sclerosis	9.52e-05	0.000677	CcSEcCtD
Pimozide—CHRM2—Signaling by GPCR—IL2—multiple sclerosis	8.87e-06	5.02e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—CD80—multiple sclerosis	8.79e-06	4.98e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—TYK2—multiple sclerosis	8.71e-06	4.93e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—TYK2—multiple sclerosis	8.71e-06	4.93e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—CD80—multiple sclerosis	8.71e-06	4.93e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—CD80—multiple sclerosis	8.71e-06	4.93e-05	CbGpPWpGaD
Pimozide—CALM2—Innate Immune System—MAPK1—multiple sclerosis	8.7e-06	4.93e-05	CbGpPWpGaD
Pimozide—CALM1—Innate Immune System—MAPK1—multiple sclerosis	8.7e-06	4.93e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CD86—multiple sclerosis	8.64e-06	4.89e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—TYK2—multiple sclerosis	8.6e-06	4.87e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—APOE—multiple sclerosis	8.54e-06	4.83e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—TYK2—multiple sclerosis	8.52e-06	4.82e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CCL5—multiple sclerosis	8.51e-06	4.81e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—IL2—multiple sclerosis	8.46e-06	4.79e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling by GPCR—IL6—multiple sclerosis	8.42e-06	4.77e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—APOE—multiple sclerosis	8.4e-06	4.75e-05	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—APOE—multiple sclerosis	8.39e-06	4.75e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—BCHE—multiple sclerosis	8.39e-06	4.75e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—APOE—multiple sclerosis	8.38e-06	4.74e-05	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—APOE—multiple sclerosis	8.38e-06	4.74e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CD86—multiple sclerosis	8.36e-06	4.73e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CD86—multiple sclerosis	8.36e-06	4.73e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—POMC—multiple sclerosis	8.35e-06	4.73e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—IL2—multiple sclerosis	8.34e-06	4.72e-05	CbGpPWpGaD
Pimozide—CALM3—Metabolism—APOE—multiple sclerosis	8.34e-06	4.72e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling by GPCR—IL6—multiple sclerosis	8.3e-06	4.7e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—APOE—multiple sclerosis	8.25e-06	4.67e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—TYK2—multiple sclerosis	8.23e-06	4.66e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CCL5—multiple sclerosis	8.23e-06	4.66e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CCL5—multiple sclerosis	8.23e-06	4.66e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—CCL2—multiple sclerosis	8.17e-06	4.63e-05	CbGpPWpGaD
Pimozide—CALM1—Metabolism—APOE—multiple sclerosis	8.07e-06	4.57e-05	CbGpPWpGaD
Pimozide—CALM2—Metabolism—APOE—multiple sclerosis	8.07e-06	4.57e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—MMP9—multiple sclerosis	8.01e-06	4.53e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling by GPCR—MAPK1—multiple sclerosis	8e-06	4.53e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—TYK2—multiple sclerosis	7.96e-06	4.51e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—TYK2—multiple sclerosis	7.96e-06	4.51e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—MMP9—multiple sclerosis	7.9e-06	4.47e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—SPP1—multiple sclerosis	7.88e-06	4.46e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—CD80—multiple sclerosis	7.72e-06	4.37e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—IFNG—multiple sclerosis	7.71e-06	4.36e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CCR5—multiple sclerosis	7.66e-06	4.34e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—SPP1—multiple sclerosis	7.62e-06	4.31e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—SPP1—multiple sclerosis	7.62e-06	4.31e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—TYK2—multiple sclerosis	7.6e-06	4.3e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—CD80—multiple sclerosis	7.59e-06	4.3e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—CD80—multiple sclerosis	7.58e-06	4.29e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—IL2RA—multiple sclerosis	7.55e-06	4.28e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—IL2—multiple sclerosis	7.5e-06	4.24e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—CD80—multiple sclerosis	7.46e-06	4.22e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—IFNG—multiple sclerosis	7.46e-06	4.22e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—IFNG—multiple sclerosis	7.46e-06	4.22e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—CD4—multiple sclerosis	7.44e-06	4.21e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—TYK2—multiple sclerosis	7.42e-06	4.2e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CCR5—multiple sclerosis	7.41e-06	4.2e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CCR5—multiple sclerosis	7.41e-06	4.2e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—TYK2—multiple sclerosis	7.35e-06	4.16e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—TYK2—multiple sclerosis	7.35e-06	4.16e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—POMC—multiple sclerosis	7.33e-06	4.15e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—IL2RA—multiple sclerosis	7.31e-06	4.14e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—IL2RA—multiple sclerosis	7.31e-06	4.14e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—IL2—multiple sclerosis	7.25e-06	4.1e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—IL2—multiple sclerosis	7.25e-06	4.1e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—POMC—multiple sclerosis	7.22e-06	4.08e-05	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—POMC—multiple sclerosis	7.21e-06	4.08e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—CD4—multiple sclerosis	7.2e-06	4.08e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—CD4—multiple sclerosis	7.2e-06	4.08e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—POMC—multiple sclerosis	7.2e-06	4.08e-05	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—POMC—multiple sclerosis	7.19e-06	4.07e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—CCL2—multiple sclerosis	7.18e-06	4.06e-05	CbGpPWpGaD
Pimozide—CALM3—Metabolism—POMC—multiple sclerosis	7.16e-06	4.05e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—IL2—multiple sclerosis	7.15e-06	4.05e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—STAT3—multiple sclerosis	7.12e-06	4.03e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling by GPCR—IL6—multiple sclerosis	7.12e-06	4.03e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—IL2—multiple sclerosis	7.09e-06	4.01e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—POMC—multiple sclerosis	7.08e-06	4.01e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—CCL2—multiple sclerosis	7.06e-06	4e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling by GPCR—IL6—multiple sclerosis	7.05e-06	3.99e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—CCL2—multiple sclerosis	7.05e-06	3.99e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling by GPCR—MAPK1—multiple sclerosis	7.02e-06	3.97e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—STAT3—multiple sclerosis	7.02e-06	3.97e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—APOE—multiple sclerosis	6.97e-06	3.95e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—CCL2—multiple sclerosis	6.93e-06	3.92e-05	CbGpPWpGaD
Pimozide—CALM2—Metabolism—POMC—multiple sclerosis	6.93e-06	3.92e-05	CbGpPWpGaD
Pimozide—CALM1—Metabolism—POMC—multiple sclerosis	6.93e-06	3.92e-05	CbGpPWpGaD
Pimozide—CALM3—Innate Immune System—IL6—multiple sclerosis	6.91e-06	3.91e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling by GPCR—MAPK1—multiple sclerosis	6.91e-06	3.91e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling by GPCR—MAPK1—multiple sclerosis	6.89e-06	3.9e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—IL1B—multiple sclerosis	6.88e-06	3.89e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—CD4—multiple sclerosis	6.87e-06	3.89e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—IL2—multiple sclerosis	6.85e-06	3.88e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—MAPK1—multiple sclerosis	6.78e-06	3.84e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—MMP9—multiple sclerosis	6.77e-06	3.83e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—APOE—multiple sclerosis	6.75e-06	3.82e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—APOE—multiple sclerosis	6.75e-06	3.82e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—MMP9—multiple sclerosis	6.71e-06	3.8e-05	CbGpPWpGaD
Pimozide—CALM2—Innate Immune System—IL6—multiple sclerosis	6.69e-06	3.78e-05	CbGpPWpGaD
Pimozide—CALM1—Innate Immune System—IL6—multiple sclerosis	6.69e-06	3.78e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—IL1B—multiple sclerosis	6.65e-06	3.76e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—IL1B—multiple sclerosis	6.65e-06	3.76e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—CD4—multiple sclerosis	6.65e-06	3.76e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—CD4—multiple sclerosis	6.65e-06	3.76e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—IL2—multiple sclerosis	6.63e-06	3.75e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—IL2—multiple sclerosis	6.63e-06	3.75e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—MYC—multiple sclerosis	6.62e-06	3.75e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—TGFB1—multiple sclerosis	6.6e-06	3.74e-05	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—ALB—multiple sclerosis	6.57e-06	3.72e-05	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—ALB—multiple sclerosis	6.56e-06	3.71e-05	CbGpPWpGaD
Pimozide—CALM3—Metabolism—ALB—multiple sclerosis	6.53e-06	3.7e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—MYC—multiple sclerosis	6.52e-06	3.69e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—TYK2—multiple sclerosis	6.52e-06	3.69e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—TGFB1—multiple sclerosis	6.51e-06	3.68e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—MAPK1—multiple sclerosis	6.48e-06	3.66e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—APOE—multiple sclerosis	6.47e-06	3.66e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—BCHE—multiple sclerosis	6.47e-06	3.66e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—TYK2—multiple sclerosis	6.41e-06	3.63e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—TYK2—multiple sclerosis	6.4e-06	3.62e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—MAPK1—multiple sclerosis	6.38e-06	3.61e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—APOE—multiple sclerosis	6.32e-06	3.58e-05	CbGpPWpGaD
Pimozide—CALM1—Metabolism—ALB—multiple sclerosis	6.32e-06	3.58e-05	CbGpPWpGaD
Pimozide—CALM2—Metabolism—ALB—multiple sclerosis	6.32e-06	3.58e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CD80—multiple sclerosis	6.3e-06	3.57e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—TYK2—multiple sclerosis	6.29e-06	3.56e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—IL2—multiple sclerosis	6.18e-06	3.49e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling by GPCR—IL6—multiple sclerosis	6.14e-06	3.48e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CD80—multiple sclerosis	6.1e-06	3.45e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CD80—multiple sclerosis	6.1e-06	3.45e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—STAT3—multiple sclerosis	6.02e-06	3.41e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—POMC—multiple sclerosis	5.99e-06	3.39e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—STAT3—multiple sclerosis	5.96e-06	3.37e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—APOE—multiple sclerosis	5.96e-06	3.37e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CCL2—multiple sclerosis	5.86e-06	3.32e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—MMP9—multiple sclerosis	5.84e-06	3.31e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—POMC—multiple sclerosis	5.79e-06	3.28e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—POMC—multiple sclerosis	5.79e-06	3.28e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—STAT3—multiple sclerosis	5.76e-06	3.26e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—MAPK1—multiple sclerosis	5.73e-06	3.25e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CCL2—multiple sclerosis	5.67e-06	3.21e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CCL2—multiple sclerosis	5.67e-06	3.21e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—MYC—multiple sclerosis	5.59e-06	3.17e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—TGFB1—multiple sclerosis	5.58e-06	3.16e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—STAT3—multiple sclerosis	5.58e-06	3.16e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—STAT3—multiple sclerosis	5.58e-06	3.16e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—POMC—multiple sclerosis	5.56e-06	3.15e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—MAPK1—multiple sclerosis	5.55e-06	3.14e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—MAPK1—multiple sclerosis	5.55e-06	3.14e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—MYC—multiple sclerosis	5.54e-06	3.14e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—TGFB1—multiple sclerosis	5.53e-06	3.13e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—MAPK1—multiple sclerosis	5.47e-06	3.1e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—POMC—multiple sclerosis	5.43e-06	3.07e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—IL2—multiple sclerosis	5.42e-06	3.07e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—MAPK1—multiple sclerosis	5.42e-06	3.07e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling by GPCR—IL6—multiple sclerosis	5.39e-06	3.05e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—IL2—multiple sclerosis	5.33e-06	3.02e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—IL2—multiple sclerosis	5.32e-06	3.01e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—TYK2—multiple sclerosis	5.32e-06	3.01e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—STAT3—multiple sclerosis	5.32e-06	3.01e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling by GPCR—IL6—multiple sclerosis	5.31e-06	3e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling by GPCR—IL6—multiple sclerosis	5.3e-06	3e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—MAPK1—multiple sclerosis	5.24e-06	2.97e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—IL2—multiple sclerosis	5.24e-06	2.96e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—IL6—multiple sclerosis	5.21e-06	2.95e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—STAT3—multiple sclerosis	5.2e-06	2.94e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—TYK2—multiple sclerosis	5.15e-06	2.91e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—TYK2—multiple sclerosis	5.15e-06	2.91e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—STAT3—multiple sclerosis	5.15e-06	2.91e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—STAT3—multiple sclerosis	5.15e-06	2.91e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—MMP9—multiple sclerosis	5.13e-06	2.9e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—POMC—multiple sclerosis	5.12e-06	2.9e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—ALB—multiple sclerosis	5.07e-06	2.87e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—MAPK1—multiple sclerosis	5.07e-06	2.87e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—MAPK1—multiple sclerosis	5.07e-06	2.87e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—MMP9—multiple sclerosis	5.05e-06	2.86e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—APOE—multiple sclerosis	5.05e-06	2.86e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—MMP9—multiple sclerosis	5.04e-06	2.85e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—IL6—multiple sclerosis	4.98e-06	2.82e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—MMP9—multiple sclerosis	4.96e-06	2.81e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—ALB—multiple sclerosis	4.95e-06	2.8e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—MYC—multiple sclerosis	4.94e-06	2.8e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—TGFB1—multiple sclerosis	4.93e-06	2.79e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—IL6—multiple sclerosis	4.9e-06	2.78e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—MAPK1—multiple sclerosis	4.84e-06	2.74e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—MYC—multiple sclerosis	4.83e-06	2.73e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—TGFB1—multiple sclerosis	4.82e-06	2.73e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—MYC—multiple sclerosis	4.78e-06	2.71e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—MYC—multiple sclerosis	4.78e-06	2.71e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—TGFB1—multiple sclerosis	4.77e-06	2.7e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—TGFB1—multiple sclerosis	4.77e-06	2.7e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—MAPK1—multiple sclerosis	4.72e-06	2.67e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—MAPK1—multiple sclerosis	4.68e-06	2.65e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—MAPK1—multiple sclerosis	4.68e-06	2.65e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—ALB—multiple sclerosis	4.66e-06	2.64e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—STAT3—multiple sclerosis	4.56e-06	2.58e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—STAT3—multiple sclerosis	4.49e-06	2.54e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—STAT3—multiple sclerosis	4.48e-06	2.54e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—IL2—multiple sclerosis	4.43e-06	2.51e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—STAT3—multiple sclerosis	4.41e-06	2.49e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—IL6—multiple sclerosis	4.41e-06	2.49e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—POMC—multiple sclerosis	4.33e-06	2.45e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—IL2—multiple sclerosis	4.28e-06	2.42e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—IL2—multiple sclerosis	4.28e-06	2.42e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—IL6—multiple sclerosis	4.26e-06	2.41e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—IL6—multiple sclerosis	4.26e-06	2.41e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—MYC—multiple sclerosis	4.24e-06	2.4e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—TGFB1—multiple sclerosis	4.23e-06	2.39e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—IL6—multiple sclerosis	4.2e-06	2.38e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—MMP9—multiple sclerosis	4.19e-06	2.37e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—MYC—multiple sclerosis	4.17e-06	2.36e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—IL6—multiple sclerosis	4.16e-06	2.36e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—MYC—multiple sclerosis	4.16e-06	2.36e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—TGFB1—multiple sclerosis	4.16e-06	2.36e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—TGFB1—multiple sclerosis	4.15e-06	2.35e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—MAPK1—multiple sclerosis	4.15e-06	2.35e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—MYC—multiple sclerosis	4.1e-06	2.32e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—TGFB1—multiple sclerosis	4.09e-06	2.31e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—MAPK1—multiple sclerosis	4.08e-06	2.31e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—MAPK1—multiple sclerosis	4.07e-06	2.3e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—MMP9—multiple sclerosis	4.05e-06	2.29e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—MMP9—multiple sclerosis	4.05e-06	2.29e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—IL6—multiple sclerosis	4.03e-06	2.28e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—MAPK1—multiple sclerosis	4.01e-06	2.27e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—ALB—multiple sclerosis	3.95e-06	2.24e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—IL6—multiple sclerosis	3.89e-06	2.2e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—IL6—multiple sclerosis	3.89e-06	2.2e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—APOE—multiple sclerosis	3.89e-06	2.2e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—STAT3—multiple sclerosis	3.73e-06	2.11e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—IL6—multiple sclerosis	3.72e-06	2.1e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—IL6—multiple sclerosis	3.63e-06	2.05e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—STAT3—multiple sclerosis	3.6e-06	2.04e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—STAT3—multiple sclerosis	3.6e-06	2.04e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—IL6—multiple sclerosis	3.6e-06	2.04e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—IL6—multiple sclerosis	3.6e-06	2.04e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—MYC—multiple sclerosis	3.46e-06	1.96e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—TGFB1—multiple sclerosis	3.45e-06	1.96e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—MAPK1—multiple sclerosis	3.39e-06	1.92e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—MYC—multiple sclerosis	3.35e-06	1.9e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—MYC—multiple sclerosis	3.35e-06	1.9e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—POMC—multiple sclerosis	3.34e-06	1.89e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—TGFB1—multiple sclerosis	3.34e-06	1.89e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—TGFB1—multiple sclerosis	3.34e-06	1.89e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—MAPK1—multiple sclerosis	3.28e-06	1.85e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—MAPK1—multiple sclerosis	3.28e-06	1.85e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—IL6—multiple sclerosis	3.19e-06	1.8e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—IL6—multiple sclerosis	3.14e-06	1.77e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—IL6—multiple sclerosis	3.13e-06	1.77e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—IL6—multiple sclerosis	3.08e-06	1.74e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—ALB—multiple sclerosis	3.05e-06	1.73e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—IL6—multiple sclerosis	2.6e-06	1.47e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—IL6—multiple sclerosis	2.52e-06	1.43e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—IL6—multiple sclerosis	2.52e-06	1.43e-05	CbGpPWpGaD
